NCT04943913View on ClinicalTrials.gov

Study on TIL for the Treatment of Brain Glioma

EARLY_PHASE1RecruitingINTERVENTIONAL
Enrollment

50

Participants

Timeline

Start Date

May 6, 2021

Primary Completion Date

December 30, 2024

Study Completion Date

May 31, 2025

Conditions
Glioma
Interventions
BIOLOGICAL

Tumor Infiltrating Lymphocytes (TIL)

Adoptive transfer of 1x10\^9-5x10\^10 autologous TILs to patients i.v. in 30-120 minutes.

Trial Locations (1)

Unknown

RECRUITING

The Second Affiliated Hospital of Soochow University, Suzhou

All Listed Sponsors
collaborator

Second Affiliated Hospital of Soochow University

OTHER

lead

Shanghai Juncell Therapeutics

INDUSTRY